Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
JoAnn V. Pinkerton(University of Virginia), Lineke Zuurman(Bayer (Switzerland)), Cláudio N. Soares(Queen's University), Nick Panay(Imperial College Healthcare NHS Trust), Rebecca C. Thurston(University of Pittsburgh), Susanne Parke(Bayer (Germany)), Hadine Joffe(Harvard University), Uwe Mellinger(Bayer (Germany)), Pauline M. Maki(University of Illinois Chicago), Ulrike Krahn(Bayer (Germany)), James A. Simon(George Washington University), Nazanin Haseli Mashhadi(Bayer (United Kingdom)), Rossella E. Nappi(University of Pavia), Christian Seitz(Bayer (Germany)), Cecilia Caetano(Bayer (Switzerland)), Claudia Haberland(Bayer (Germany))
Cited by 90
Related Papers
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
|Climacteric|2016|958
Recommendations for the management of postmenopausal vaginal atrophy
|Climacteric|2010|526
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
|New England Journal of Medicine|2017|492
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
|New England Journal of Medicine|2008|469